| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 07/08/2009 | EP1660103A4 Enhancement of magnesium uptake in mammals |
| 07/08/2009 | EP1536768B1 Biodegradable composition with prolonged release of an antitumour agent and preparation thereof |
| 07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
| 07/08/2009 | CN101478977A Treatment of neurodegenerative diseases |
| 07/08/2009 | CN101474206A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN101474205A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN101474204A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN101474203A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN101474202A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN101474201A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN101474200A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN101474199A Pharmaceutical composition for reducing blood fat |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508989C Medicinal powder for treating beriberi |
| 07/08/2009 | CN100508988C Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 07/07/2009 | US7557142 Administering otoprotective agent comprising methionine or derivative to patient undergoing chemotherapy; side effect reduction |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556824 Transdermal patch comprising hydralazine derivative antioxidant and isosorbide di- and/or mononitrate |
| 07/07/2009 | US7556150 Dispenser for progestin used for acute and maintenance treatment of DUB |
| 07/07/2009 | CA2388809C A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 07/07/2009 | CA2344910C Method for treating renal disease, and pharmaceutical composition for treating renal disease |
| 07/02/2009 | WO2009082363A1 Method and preparations for treating infection-allergic diseases |
| 07/02/2009 | WO2009082348A1 Novel crystalline form c of (2r)-(3-amino-2-fluoropropyl)phosphinic acid |
| 07/02/2009 | WO2009082345A1 Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid |
| 07/02/2009 | WO2009082344A1 Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a |
| 07/02/2009 | WO2009027594A3 Strontium doped bioactive glasses |
| 07/02/2009 | WO2008141268A3 Enhancement of the calcium sensing receptor |
| 07/02/2009 | WO2008063943A4 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 07/02/2009 | US20090169649 Treatment of neurodegenerative diseases |
| 07/02/2009 | US20090169648 Compositions to reduce blood glucose levels and treat diabetes |
| 07/02/2009 | US20090169646 Methods of treating cystic fibrosis |
| 07/02/2009 | US20090169645 Iron Sulfate-Based Phosphate Adsorbent |
| 07/02/2009 | US20090169644 Antidandruff Shampoo |
| 07/02/2009 | US20090169643 Composition for Enhancing Immune Function |
| 07/02/2009 | US20090169600 Hydrogen Peroxide Delivery System |
| 07/02/2009 | US20090169524 Composites and methods of preparation and use thereof |
| 07/02/2009 | DE102005053384B4 Mittel zur Behandlung von Verätzungen mit Fluorwasserstoffsäure Agents for the treatment of burns with hydrofluoric acid |
| 07/01/2009 | EP2075031A1 Methods and systems for enhancing fluid flow trough an obstructed vascular site |
| 07/01/2009 | EP2073821A1 Mixture of iron and copper salts masking metallic taste |
| 07/01/2009 | EP2005964A9 The medicament for treating hyperphospheremia and preparation thereof |
| 07/01/2009 | CN101468037A Paste for treating pain caused by burn and formulating method thereof |
| 07/01/2009 | CN101468036A Soluble powder for preventing and treating heat stress of fowl |
| 07/01/2009 | CN100506287C Method for preparing radioactive arsenic compound and usage for curing tumor |
| 06/30/2009 | US7553817 Ribose; enhancing ATP recovery and synthesis; increasing exercise capacity |
| 06/30/2009 | US7553482 Preventing atherosclerotic disease, bone disorders by administering iron(III) oxide hydroxide-carbohydrate complexes; for reducing the calcium phosphate product, calcium level in the blood; side effect reduction; controlling blood metal concentration |
| 06/30/2009 | US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
| 06/30/2009 | CA2527365C Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| 06/30/2009 | CA2359874C Method for reducing hip joint laxity |
| 06/30/2009 | CA2188319C Coated products with potent anti-hiv and antimicrobial properties |
| 06/25/2009 | WO2009079401A2 Compositions and methods for increasing iron absorption |
| 06/25/2009 | WO2009078474A1 An agent for reducing a side effect of an anticancer drug |
| 06/25/2009 | US20090162454 Compositions and Methods for Effecting NAD+ Levels Using A Nicotinamide Phosphoribosyl Tranferase Inhibitor |
| 06/25/2009 | US20090162448 Metal Carbonate Particles and Methods of Making Thereof |
| 06/25/2009 | US20090162446 Absorbent article having a stable skin care composition |
| 06/25/2009 | US20090162443 Compositions and methods for reducing or preventing water loss from the skin |
| 06/25/2009 | US20090162440 Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof |
| 06/25/2009 | US20090162429 Slow-Release Composition, Method for the Preparation Thereof, and Use Thereof |
| 06/25/2009 | US20090162406 Wound healing with zeolite-based hemostatic devices |
| 06/25/2009 | US20090162335 Melatonin and immunostimulating substance-based compositions |
| 06/25/2009 | US20090162301 Antiseptic Compositions |
| 06/25/2009 | US20090162288 Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods |
| 06/25/2009 | CA2709463A1 Trail variants for treating cancer |
| 06/25/2009 | CA2709159A1 Compositions and methods for increasing iron absorption |
| 06/24/2009 | EP2072046A1 Use of a hydrocarbon-containing preparation for preventing or treating cardiac-circulatory diseases, diabetes, osteoporosis and chronic liver failure |
| 06/24/2009 | EP1651246A4 Method for promoting bone growth |
| 06/24/2009 | CN101466388A Antimicrobial carbon |
| 06/24/2009 | CN101466387A Use of gallium(III) complexes for the treatment of melanomas |
| 06/24/2009 | CN101461825A Chinese medicine spray for eliminating osmidrosis |
| 06/24/2009 | CN101461824A Solution for eliminating hemorrhoids |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503435C Nano level active carbon and its preparation and use |
| 06/24/2009 | CN100502890C Amoxicillin antibacterial agent containing nano silver, and its preparing method |
| 06/24/2009 | CN100502889C Oral and dental composition |
| 06/24/2009 | CN100502650C Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 06/23/2009 | US7550584 Methods of purifying beta glucans |
| 06/23/2009 | US7550157 Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 06/23/2009 | CA2320628C Chelated 8-hydroxyquinoline for the treatment of epithelial lesions |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/18/2009 | WO2009075774A2 Glycosaminoglycan-coated particles and uses thereof |
| 06/18/2009 | WO2009075216A1 Therapeutic agent for ulcer |
| 06/18/2009 | WO2009074823A1 Composition for the treatment of a detached retina and method of production thereof |
| 06/18/2009 | WO2009074305A1 Gold xanthogenates and medicaments comprising them |
| 06/18/2009 | US20090156693 Ophthalmic compositions containing polysaccharide/borate gelling system |
| 06/18/2009 | US20090156688 Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 06/18/2009 | US20090155391 Hydroxycitric acid salt composition and method of use for reducing body weight |
| 06/18/2009 | US20090155390 Composition and method of treating temporary and permanent hearing loss |
| 06/18/2009 | US20090155389 Selective serotonin receptor inverse agonists as therapeutics for disease |
| 06/18/2009 | US20090155388 Weight phyto-nutraceutical synergistic composition |
| 06/18/2009 | US20090155387 Stable pharmaceutical composition comprising beta-lactam antibiotic and ion-chelating agent |
| 06/18/2009 | US20090155384 Methods and compositions for the sustained release of chromium |
| 06/18/2009 | US20090155383 Personal Care Compositions Comprising Undecyl Sulfates |
| 06/18/2009 | US20090155382 Methods and Compositions for Heavy Metal Detoxification |
| 06/18/2009 | US20090155381 Method of treatment or prevention of age-related macular degeneration |
| 06/18/2009 | US20090155380 Non-medicinal food additive for animals, supplemented foods containing same and method for improving animal growth |
| 06/18/2009 | US20090155379 Nutritional composition for facilitating muscle pumps |
| 06/18/2009 | US20090155371 Compositions Comprising Solid Particles Entrapped In Collapsed Polymeric Microspheres, And Methods Of Making The Same |
| 06/18/2009 | US20090155367 Occlusion of Fallopian Tubes |
| 06/18/2009 | US20090155342 Mineral technologies (MT) for acute hemostasis and for the treatment of acute wounds and chronic ulcers |
| 06/18/2009 | US20090155337 Method and agent for in-situ stabilization of vascular tissue |
| 06/18/2009 | US20090155318 Process to form nano-sized materials, the compositions and uses thereof |